Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.631,59
0,53%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aptevo Therapeutics Inc (APVO) Aptevo Therapeutics Inc (APVO) Notizie

Aptevo Therapeutics Inc

APVO
0,319
-0,1959 (-38,05%)
29 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202422:30EDGAR2Form S-1 - General form for registration of securities under..
10/6/202422:30EDGAR2Form 8-K - Current report
03/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:15EDGAR2Form 8-K - Current report
07/3/202414:56EDGAR2Form 8-K - Current report
05/3/202423:05EDGAR2Form 8-K - Current report
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202414:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202414:15EDGAR2Form 8-K - Current report
06/2/202422:37EDGAR2Form 8-K - Current report
31/1/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202414:00EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
16/1/202422:15EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
22/12/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
12/12/202322:19EDGAR2Form PRE 14A - Other preliminary proxy statements
01/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202322:05EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202323:17EDGAR2Form 8-K - Current report
03/11/202321:15EDGAR2Form 8-K - Current report
15/9/202322:30EDGAR2Form 8-K - Current report
10/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202314:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:16EDGAR2Form 8-K - Current report
03/8/202323:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
01/8/202322:01EDGAR2Form S-1/A - General form for registration of securities..
18/7/202314:16EDGAR2Form 8-K - Current report
14/7/202322:16EDGAR2Form S-1/A - General form for registration of securities..
30/6/202322:16EDGAR2Form S-1 - General form for registration of securities under..
Apertura: 0,4187 Min: 0,3005 Max: 0,4286
Chiusura: 0,5149

La tua Cronologia

NASDAQ
APVO
Aptevo Therapeutics
LSE
42WQ
Cred Ag Co 26
TG
EX9
Exelixis Inc Dl 01
LSE
51HC
Cred Ag Co 23
NASDAQ
WSIID
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network